Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis

Hepatobiliary and Pancreatic Diseases International

Volumn 5, Issue 2, 2006, Pages 224-227

  Wen, Jun ^a   Shen, Wen Lv ^a   Yang, Shao Hua ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Carcinoma, hepatocellular; Chemotherapy; Hepatitis B virus cirrhosis; Resection

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; DOXORUBICIN; FLOXURIDINE; HERBACEOUS AGENT; MITOMYCIN C;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CHINESE MEDICINE; CLINICAL ARTICLE; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; LEUKOCYTE COUNT; LEUKOPENIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER RESECTION; MALE; NAUSEA; POSTOPERATIVE CARE; PRESCRIPTION; RETROSPECTIVE STUDY; TUMOR VOLUME; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; CHEMOTHERAPY, ADJUVANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATITIS B, CHRONIC; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33744800798     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Cha CH, Ruo L, Fong Y, Jamagin WR, Shia J, Blumgart LH, et al. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg 2003; 228: 315-323.
2. Sutcliffe R, Maguire D, Portmann B, Rela M, Heaton N. Selection of patients with hepatocellular carcinoma for liver transplantation. Br J Surg 2006;93:11-18.
3. Poon RT, Fan ST, Lo CM, Ng IO, Liu CL, Lam CM, et al. Improving survival results after resection of hepatocellular carcinoma; a prospective study of 377 patients over 10 years. Ann Surg 2001;234:63-70.
4. Grazi GL, Ercolani G, Pierangeli F, Gaudio MD, Cescon M, Cavallari A, et al. Improved results of liver resections for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 2001;234:71-78.
5. Cheon JH, Park JW, Park KW, Kim YI, Kim SH, Lee WJ, et al. The clinical report of 1078 cases of hepatocellular carcinomas: Natiomas: National Cancer Center experience. Korean J Hepatol 2004;10:288-297.
6. Lang BH, Poon RT, Fan ST, Wong J. Perioperative and long-term outcome of major hepatic resection for small solitary hepatocellular carcinoma in patients with cirrhosis. Arch Surg 2003;138:1207-1213.
7. Ercolani G, Grazi GL, Ravaioli M, Gaudio MD, Gardini A, Cescon M, et al. Liver resection for hepatocellular carcinoma on cirrhosis. Ann Surg 2003;237:536-543.
8. Fong Y, Sun PL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999;229:790-799.
9. Poon RT, Fan ST, Lo CM, Liu CL, Ng IO, Wong J. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol 2000;18:1094-1101.
10. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991;214:114-117.
11. Adachi E, Maeda T, Matsumata T, Shirabe K, Kinukawa N, Sugimachi K, et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995; 108:768-775.
12. Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 1997;25:87-92.
13. Park JW, Park KW, Cho SH, Park HS, Less WJ, Lee do H, et al. Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: report of a prospective study. Am J Gastroenterol 2005;100:2194-2200.
14. Wakabayashi H, Ushiyama T, Ishimura K, Izuishi K, Karasawa Y, Masaki T, et al. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions. J Surg Oncol 2003;82: 98-103
15. Lai EC, Lo CM, Fan ST, Liu CL, Wong J. Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg 1998; 133:183-188.
16. Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, et al. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomized trial. Lancet 2000;356:802-807.
17. Nagao T, Inoue S, Yoshimi F, Sodeyama M, Omori Y, Mizuta T, et al. Postoperative recurrence of hepatocellular carcinoma. Ann Surg 1990;211:28-33.
18. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J, et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000;89:500-507.